Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AlphaCord is a leading private newborn stem cell bank specializing in the collection, processing, and cryopreservation of umbilical cord blood and cord tissue. The company provides families with a biological insurance policy by securing hematopoietic and mesenchymal stem cells that can be used in the treatment of numerous hematological, oncological, and metabolic disorders. AlphaCord distinguishes itself in the market through its commitment to affordability without compromising on clinical quality, utilizing FDA-registered and AABB-accredited laboratory facilities. Beyond stem cell banking, the company offers supplemental services such as newborn genetic screening and placenta tissue banking to support comprehensive family health planning.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AlphaCord.